
1 
These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2010 and shall come into operation on 16th April 2010.
2 

(1) In these Regulations, “the 2002 Regulations” means the Misuse of Drugs Regulations (Northern Ireland) 2002.
(2) The Interpretation Act (Northern Ireland) 1954 shall apply to these Regulations as it applies to an Act of the Assembly.
3 
The 2002 Regulations shall be amended as follows.
4 
In Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—
(a) in paragraph 1(a), after ”Methcathinone”, insert—“4–Methylmethcathinone”;
(b) after paragraph 1(1), insert—“
(m) Any compound (not being bupropion, diethylpropion, pyrovalerone or a compound for the time being specified in sub-paragraph (a) above) structurally derived from 2-amino-1–phenyl-1–propanone by modification in any of the following ways, that is to say—
(i) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(ii) by substitution at the 3-position with an alkyl substituent;
(iii) by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure”.
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 12th April 2010
(L.S.)Norman Morrow
A senior officer of the Department of Health, Social Services and Public Safety
